Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18567,71,13.34 [5.63-31.60],3.877133794828786e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18572,71,2.90 [2.05-4.11],2.2468739483169957e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15560,59,4.56 [3.16-6.58],5.365531643133178e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15336,58,1.89 [1.55-2.29],1.6466948757496175e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18555,70,2.94 [2.37-3.65],1.3449875722897561e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18014,68,1.90 [1.52-2.38],1.94575533579984e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18039,70,2.04 [1.64-2.53],1.8181905638829016e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18492,70,12.54 [7.50-20.97],5.152099419985515e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,15980,64,1.92 [1.67-2.20],1.3450014215564091e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,15956,64,2.53 [2.15-2.97],1.289229127561338e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15528,61,3.48 [2.94-4.10],5.544448011559757e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15528,61,3.06 [2.22-4.21],6.930347308297421e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,15980,64,3.27 [2.60-4.10],2.287492947519362e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18369,70,19.40 [7.42-50.71],1.4542729701687543e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,15987,64,1.68 [1.43-1.97],3.633429720032063e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18427,71,1.60 [1.38-1.85],3.262106066475151e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18427,71,4.95 [3.98-6.14],2.6602143002628653e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18653,71,3.79 [3.01-4.76],3.1342275574121703e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18477,72,7.05 [5.21-9.52],5.390237159785394e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18014,68,2.38 [1.84-3.07],3.031647528605997e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18471,70,20.23 [13.49-30.34],5.928745916623256e-48
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18580,70,4.96 [4.16-5.92],2.000473217231505e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18620,71,5.60 [3.98-7.88],5.808791068616979e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18427,71,5.70 [4.53-7.17],5.126821329636285e-50
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15659,64,7.74 [5.90-10.17],4.535583433443921e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18597,71,10.70 [7.32-15.64],2.161029121393215e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18653,71,6.35 [5.18-7.79],1.646843146246969e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16007,62,7.68 [5.44-10.85],5.69947617209877e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18427,71,5.97 [3.74-9.54],8.127691696299649e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",15980,64,2.62 [2.00-3.45],4.103807820646019e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18562,71,3.46 [2.55-4.68],9.891409404142223e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15528,61,4.16 [2.68-6.47],2.2054360888742158e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18427,71,2.91 [2.05-4.13],2.1429405609701754e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,15980,64,4.16 [2.65-6.52],5.144209748852256e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16007,62,3.51 [2.38-5.17],2.0743647935477384e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18520,69,3.31 [2.24-4.89],1.7280881808983975e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,17988,68,1.95 [1.56-2.43],4.1186510624004755e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18284,71,4.51 [3.18-6.39],2.239994398991996e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15864,63,2.11 [1.77-2.51],2.6933971890506402e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15792,64,3.43 [2.70-4.35],4.110714276100687e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18432,70,5.16 [3.11-8.56],2.18388679696374e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18597,71,7.06 [3.54-14.05],2.6749510719268444e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,15951,63,2.32 [1.83-2.93],3.270816730709641e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18284,71,2.15 [1.68-2.75],1.649490742759635e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18344,71,5.02 [3.08-8.17],9.090514533566212e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18344,71,7.04 [4.53-10.94],3.7380146972071385e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18250,71,9.41 [6.99-12.67],2.1472761662590146e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18427,71,1.90 [1.65-2.20],1.607615006600753e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18344,71,2.25 [1.99-2.56],1.3027646089953896e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15485,61,3.64 [2.44-5.44],2.4228764359884776e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18578,70,5.71 [3.81-8.56],3.425108432197204e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15731,62,3.55 [2.69-4.69],4.6487569052595695e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18597,71,6.73 [4.62-9.81],2.933980458920329e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18432,70,3.66 [3.28-4.09],3.2690046693060525e-116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18432,70,3.36 [2.75-4.10],8.096191424632299e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18569,71,3.66 [3.16-4.24],1.0081244649909783e-67
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18124,68,3.95 [3.31-4.70],1.4554728566499972e-53
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18432,70,4.93 [3.72-6.55],1.8861470190351447e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18014,68,1.58 [1.36-1.82],6.365796423060042e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18427,71,2.02 [1.58-2.59],2.1866096938109453e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,17984,68,3.98 [3.10-5.11],3.3185369129501386e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18124,68,3.23 [2.39-4.37],2.3946870477208887e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18344,71,12.66 [4.99-32.09],8.840384483599198e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,15951,63,1.91 [1.54-2.38],5.7287322772877366e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18039,70,2.32 [1.74-3.09],8.764481981054419e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18332,69,9.30 [6.50-13.30],2.6252932094855047e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,15980,64,2.42 [1.97-2.97],3.682138930066411e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18039,70,2.08 [1.66-2.61],1.8277396064729358e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,15987,64,2.02 [1.64-2.49],2.6983924015486947e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18663,72,22.24 [15.61-31.67],3.0526670423003124e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15594,64,3.98 [2.64-5.99],3.971678750640568e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18427,71,2.78 [2.19-3.54],8.761341755561712e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18344,71,4.82 [4.05-5.75],1.5415928470991078e-69
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18124,68,3.65 [2.53-5.28],5.95924785889668e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18124,68,4.52 [2.67-7.67],2.031504687668372e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18653,71,2.63 [2.06-3.36],1.0583102142715344e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18520,69,5.65 [3.44-9.28],8.227318751013179e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18317,71,4.51 [3.51-5.79],6.241724427176763e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18427,71,4.82 [3.52-6.61],1.3463182379242758e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18007,69,1.77 [1.46-2.14],6.464963829193295e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18011,70,2.18 [1.84-2.58],1.3527241768798422e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15560,59,3.44 [2.48-4.78],1.4599767769083782e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18109,70,1.64 [1.38-1.94],1.7405041783892288e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18344,71,2.63 [2.05-3.39],5.81991677414281e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18663,72,10.90 [5.82-20.41],8.243305374595985e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,15956,64,6.60 [3.99-10.92],2.078891029831017e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18427,71,6.84 [4.93-9.49],1.4470091120168123e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18427,71,5.49 [3.04-9.90],1.493588661211916e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18205,71,24.58 [17.25-35.01],2.1864261146341183e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18014,68,1.73 [1.51-1.99],1.0704622418660308e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18227,71,1.90 [1.60-2.27],8.049228408444399e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,15980,64,2.27 [1.76-2.94],2.7409940909477166e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,15980,64,3.29 [2.26-4.78],4.2119389619991957e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18124,68,2.11 [1.85-2.42],1.065312252483144e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18014,68,3.78 [2.89-4.94],1.625303661990104e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15485,61,2.48 [1.98-3.12],4.2639313183913166e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18284,71,1.83 [1.63-2.06],9.759613312485294e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18344,71,4.10 [2.50-6.72],2.42909966603854e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18427,71,1.96 [1.76-2.19],1.189386140401973e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,15956,64,9.46 [5.42-16.49],2.345317274272668e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18574,70,6.40 [4.90-8.37],5.945096613405115e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18427,71,2.94 [2.35-3.68],6.160911165748098e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15599,60,2.06 [1.66-2.56],6.621090968239888e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15523,61,2.10 [1.61-2.74],4.44977138683501e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18344,71,2.83 [2.29-3.49],3.189996113210883e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18014,68,1.93 [1.67-2.23],1.5968983793860793e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18014,68,2.21 [1.71-2.86],1.4998005397628623e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18427,71,1.99 [1.73-2.29],1.7211620978069631e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16018,64,14.63 [9.58-22.33],1.8186381778330472e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,15951,63,1.98 [1.56-2.52],1.5554687539350015e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18014,68,1.62 [1.38-1.90],6.1181280973445725e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15485,61,1.99 [1.56-2.53],2.219290311729396e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18432,70,7.02 [3.86-12.76],1.7008941551624095e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15560,59,5.53 [3.52-8.69],1.2511108843584897e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15485,61,2.24 [1.90-2.64],7.146666637244323e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15659,64,4.08 [3.35-4.95],2.6312487769848905e-45
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16032,63,10.30 [6.76-15.68],1.5942536569191218e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18603,72,5.82 [4.27-7.93],6.696356949803479e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18344,71,3.06 [2.10-4.44],5.039367769638272e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18606,70,8.64 [6.52-11.46],7.829402916901134e-51
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18124,68,2.75 [1.93-3.92],2.4264673548611578e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18014,68,4.66 [3.72-5.84],8.783286014247877e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,15956,64,2.21 [1.94-2.52],1.4579526044783269e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15485,61,1.83 [1.51-2.21],3.664248008404077e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18365,69,5.19 [3.12-8.62],2.161025473149068e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18344,71,2.77 [2.28-3.36],5.111241523415993e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18597,71,9.21 [7.32-11.59],8.300976688652306e-80
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,15956,64,2.90 [2.34-3.60],3.258622798573132e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,15980,64,2.53 [1.94-3.28],4.464741416514124e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18261,71,2.92 [2.55-3.34],6.384388373840558e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16007,62,2.87 [2.24-3.69],1.7573046103395416e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,15951,63,1.77 [1.49-2.10],6.249156002713087e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18084,70,2.10 [1.65-2.67],1.4232596052426291e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18432,70,4.35 [3.60-5.26],3.862531204197715e-52
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18124,68,4.06 [3.44-4.79],2.040906845988937e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18432,70,2.00 [1.59-2.51],2.887931556959417e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18620,71,6.02 [4.22-8.58],3.3552362113020624e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18597,71,2.84 [2.06-3.90],1.4203561009675422e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18284,71,4.68 [4.09-5.36],1.282540922118068e-110
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16018,64,3.71 [2.50-5.51],6.821748943269124e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15528,61,1.99 [1.56-2.53],2.1400336084182847e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18014,68,2.25 [1.77-2.86],2.787892943386265e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15528,61,1.94 [1.52-2.48],9.63310967228617e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18432,70,9.44 [6.47-13.75],1.6406427983251878e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18498,69,6.90 [3.75-12.68],5.112902033108282e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15528,61,2.80 [2.16-3.63],8.927538401159256e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,15980,64,2.94 [2.50-3.46],3.84070758158628e-39
